High adherence rates due to its effective, mild dosing and flexible options.
Trusted brand from Medresearch India, with a commitment to quality and patient satisfaction.
Balanced efficacy with fewer side effects, minimizing common issues like headaches and flushing.
Provides up to 36 hours of effectiveness, allowing patients flexibility without daily dosing.
High manufacturing standards ensure each tablet delivers consistent potency for dependable outcomes.
.png)
Safe for comorbidities: Erectaid T10 is carefully formulated for patients with conditions like diabetes and hypertension, which are commonly associated with ED.
Patients prefer Tadalafil for its long duration and flexible dosing. Erectaid T10 offers a mild dose that meets these preferences, leading to higher patient satisfaction and adherence.
1. Porst H, et al. (2003) : This study highlights Tadalafil's long duration of action, enabling an extended window for sexual spontaneity without the need for daily dosing. *International Journal of Impotence Research.*
2. Brock GB, et al. (2002) : Tadalafil has been shown to have a favorable safety profile with minimal side effects, making it a reliable choice for patients seeking milder doses for ED management. *European Urology.*
3. McMahon CG (2004) : Tadalafil's efficacy in diabetic patients has been supported by clinical trials, showing it as a suitable option for men with ED and comorbid diabetes. *The Journal of Sexual Medicine.*
Medresearch India is a healthcare company focused on innovation, offering pharma products, medical devices, digital health solutions, and research consulting with a commitment to quality and care.
D & D by Big A Solutions | Copyright © 2025 MedResearchIndia. All rights reserved.